These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 613561)

  • 41. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lowering of hypertension by central saralasin in the absence of plasma renin.
    Phillips MI; Mann JF; Haebara H; Hoffman WE; Dietz R; Schelling P; Ganten D
    Nature; 1977 Dec; 270(5636):445-7. PubMed ID: 593364
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of angiotensen antagonist in rats with acute, subacute, and chronic two-kidney renal hypertension.
    Carretero OA; Gulati OP
    J Lab Clin Med; 1978 Feb; 91(2):264-71. PubMed ID: 621427
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.
    Vinci JM; Horwitz D; Zusman RM; Pisano JJ; Catt KJ; Keiser HR
    Hypertension; 1979; 1(4):416-26. PubMed ID: 232086
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
    Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
    Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Angiotensin antagonists in the diagnosis and treatment of renin-dependent hypertension].
    Ganten D; Gross F
    Med Klin; 1976 Nov; 71(47):2043-50. PubMed ID: 794662
    [No Abstract]   [Full Text] [Related]  

  • 47. [Renin-angiotensin system blockers].
    Dimitrov T
    Eksp Med Morfol; 1982; 21(2):49-54. PubMed ID: 6183092
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect of activation and blockade of the renin-angiotensin system on the hypotensive activity of the cholinergic system].
    Fedorov VI
    Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):33-40. PubMed ID: 1334879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of hemorrhagic hypotension and inhibitory drugs of renin-angiotensin system upon endocrine and renal functions (author's transl)].
    Yamashita M
    Masui; 1977 Nov; 26(12):1482-93. PubMed ID: 599636
    [No Abstract]   [Full Text] [Related]  

  • 50. Haemodynamic response to converting enzyme inhibitor and saralasin in salt-depleted dogs; relation to plasma renin activity [proceedings].
    Conway J; Hatton R; Keddie J
    Br J Pharmacol; 1978 Mar; 62(3):448P. PubMed ID: 205299
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA; Mitchell HC
    Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 53. Preclinical pharmacology of saralasin.
    Castellion AW; Fulton RW
    Kidney Int Suppl; 1979 Mar; (9):S11-9. PubMed ID: 113608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 55. Concept of anti-renin system therapy. Historic perspective.
    Laragh JH
    Am J Med; 1984 Aug; 77(2A):1-6. PubMed ID: 6383032
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: Hypotension during angiotensin blockade with saralasin.
    Pettinger WA; Keeton K
    Lancet; 1975 Jun; 1(7921):1387-8. PubMed ID: 48980
    [No Abstract]   [Full Text] [Related]  

  • 57. [Role of renin-angiotensin system and its blockaders in the pathogenesis of arterial hypertension].
    Dimitrov T
    Eksp Med Morfol; 1982; 21(1):1-5. PubMed ID: 6178577
    [No Abstract]   [Full Text] [Related]  

  • 58. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 59. The renin system in essential, renovascular and adrenocortical hypertension: an overview.
    Laragh JH
    Adv Nephrol Necker Hosp; 1977; 7():157-89. PubMed ID: 96672
    [No Abstract]   [Full Text] [Related]  

  • 60. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
    Waeber B; Nussberger J; Brunner H
    Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.